Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer’s and Parkinson’s Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery
Coralie Di Scala, Nicholas Armstrong, Henri Chahinian, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13383-13383
Open Access | Times Cited: 15

Showing 15 citing articles:

Conformationally adaptive therapeutic peptides for diseases caused by intrinsically disordered proteins (IDPs). New paradigm for drug discovery: Target the target, not the arrow
Jacques Fantini, Fodil Azzaz, Coralie Di Scala, et al.
Pharmacology & Therapeutics (2025), pp. 108797-108797
Open Access | Times Cited: 2
MicroRNAs in Parkinson’s disease: From pathogenesis to diagnostics and therapeutic strategies
Dongying Zheng, Jibing Chween
Neuroscience (2025)
Closed Access | Times Cited: 1
Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future
Jacques Fantini, Henri Chahinian, Nouara Yahi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1923-1923
Open Access | Times Cited: 18
Lipid rafts and human diseases: why we need to target gangliosides
Jacques Fantini
FEBS Open Bio (2023) Vol. 13, Iss. 9, pp. 1636-1650
Open Access | Times Cited: 17
AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer’s Disease Therapy
Fodil Azzaz, Henri Chahinian, Nouara Yahi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1760-1760
Open Access | Times Cited: 14
Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies
Baoyi Li, Ulf Dettmer
Neurobiology of Disease (2024) Vol. 201, pp. 106646-106646
Open Access | Times Cited: 5
Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53
Jacques Fantini, Fodil Azzaz, Anaïs Aulas, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A Pore Forming Toxin-like Protein Derived from Chinese Red Belly Toad Bombina maxima Triggers the Pyroptosis of Hippomal Neural Cells and Impairs the Cognitive Ability of Mice
Qingqing Ye, Qiquan Wang, Wen‐Hui Lee, et al.
Toxins (2023) Vol. 15, Iss. 3, pp. 191-191
Open Access | Times Cited: 4
Optimizing nasal drug delivery for peptides, proteins, and small molecules: strategic use of materials and techniques to target the CNS
Vandana Mittal, Khushwant S. Yadav
International Journal of Polymeric Materials (2024), pp. 1-24
Closed Access | Times Cited: 1
Metallic Nanocarriers for Therapeutic Peptides: Emerging Solutions Addressing the Delivery Challenges in Brain Ailments
Shanmuga Sharan Rathnam, Thirumalai Deepak, Badri Narayana Sahoo, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 1, pp. 39-53
Open Access | Times Cited: 3
Molecular Mechanism of Alzheimer’s Disease
Gerhard Rammes
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16837-16837
Open Access | Times Cited: 3
Lyotropic Liquid Crystalline Based Nasal Spray for Improved Parkinson's Treatment: Enhanced Superior Nasal Tract Deposition and Antioxidation Strategy
Xia Xiao, Ziqiao Zhong, Cheng Wei, et al.
Advanced Functional Materials (2024)
Closed Access
Targeted Brain Delivery of Therapeutics
Akanksha Malaiya, Rameshroo Kewat, Shivani Rai Paliwal, et al.
(2024), pp. 287-308
Closed Access
The role of amphipathic and cationic helical peptides in Parkinson's disease
Carlos Pintado‐Grima, Salvador Ventura
Protein Science (2024) Vol. 34, Iss. 1
Open Access
Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s Disease
Marilena K. Theodoropoulou, Konstantina D. Vraila, Nikolaos Papandreou, et al.
Biomolecules (2024) Vol. 15, Iss. 1, pp. 28-28
Open Access
Page 1

Scroll to top